Metropolis Healthcare Ltd vs Vimta Labs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Metropolis Healthcare Ltd is ₹ 522.95 as of 23 Oct 15:30 . The P/E Ratio of Metropolis Healthcare Ltd changed from 62.6 on March 2021 to 47.3 on March 2026 . This represents a CAGR of -4.56% over 6 yearsThe P/E Ratio of Vimta Labs Ltd changed from 16.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Metropolis Healthcare Ltd changed from ₹ 11455 crore on March 2021 to ₹ 8992 crore on March 2026 . This represents a CAGR of -3.95% over 6 yearsThe Market Cap of Vimta Labs Ltd changed from ₹ 355.7 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Metropolis Healthcare Ltd for the Jun '26 is ₹ 455.32 crore as compare to the Mar '26 revenue of ₹ 432.95 crore. This represent the growth of 5.17% The revenue of Vimta Labs Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Metropolis Healthcare Ltd for the Jun '26 is ₹ 116.3 crore as compare to the Mar '26 ebitda of ₹ 116.29 crore. This represent the growth of 0.01% The ebitda of Vimta Labs Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Metropolis Healthcare Ltd changed from ₹ 38.11 crore to ₹ 56.88 crore over 9 quarters. This represents a CAGR of 19.48% The net profit of Vimta Labs Ltd changed from ₹ 12.28 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The Dividend Payout of Metropolis Healthcare Ltd changed from 20.69 % on March 2021 to 65.83 % on March 2026 . This represents a CAGR of 21.28% over 6 yearsThe Dividend Payout of Vimta Labs Ltd changed from 20.79 % on March 2021 to 11.52 % on March 2026 . This represents a CAGR of -9.37% over 6 years .

About Metropolis Healthcare Ltd

Dr. Sushil Kanubhai Shah, one of the Promoters, commenced pathology business in January 1980 as a partnership firm in the name of Dr. V. K. Desai's Hospital, having Dr. Kanubhai M. Shah, Dr. Sushil Kanubhai Shah and Dr. Vasant Kalyandas Desai as partners.
The partnership was continued by Dr. Sushil Kanubhai Shah, Dr. Kanubhai M. Shah and Dr. Duru Sushil Shah from September 30, 1981 onwards.
In June 1989, upon death of Dr. Kanubhai M. Shah, the partnership was continued by Dr. Sushil Kanubhai Shah and Dr. Duru Sushil Shah.
Prior to March 18, 1995, Dr. Sushil Kanubhai Shah was also carrying on a business of radioimmunoassay and pathology laboratory on a sole proprietorship basis.
On March 20, 1995, the said sole proprietorship business was converted into a partnership with Dr. Sushil Kanubhai Shah, Dr.

About Vimta Labs Ltd

Vimta Labs Limited., established in 1984, is India's most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries.
Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas like preclinical research (GLP and non-GLP), clinical research, central lab, and cGMP as well as non-GMP analytical services for pharmaceutical and biopharmaceutical companies; Preclinical research and testing services for medical device companies; Contract research and testing for Agro-science companies; Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators; Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil & gas, mining etc; EMI/EMC testing for electronic and electrical products.

FAQs for the comparison of Metropolis Healthcare Ltd and Vimta Labs Ltd

Which company has a larger market capitalization, Metropolis Healthcare Ltd or Vimta Labs Ltd?

Market cap of Metropolis Healthcare Ltd is 10,849 Cr while Market cap of Vimta Labs Ltd is 2,096 Cr

What are the key factors driving the stock performance of Metropolis Healthcare Ltd and Vimta Labs Ltd?

The stock performance of Metropolis Healthcare Ltd and Vimta Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Metropolis Healthcare Ltd and Vimta Labs Ltd?

As of October 25, 2026, the Metropolis Healthcare Ltd stock price is INR ₹522.95. On the other hand, Vimta Labs Ltd stock price is INR ₹468.95.

How do dividend payouts of Metropolis Healthcare Ltd and Vimta Labs Ltd compare?

To compare the dividend payouts of Metropolis Healthcare Ltd and Vimta Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.